Hypoxia controls expression of kidney-pathogenic MUC1 variants

Hypoxia or pharmacological treatment with novel HIF stabilizers promotes the expression of MUC1 genetic variants that predispose to the development of chronic kidney disease in renal tubular cells.

[1]  B. Obermayer,et al.  Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury , 2022, Genome Medicine.

[2]  B. Wullich,et al.  The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression , 2022, The Journal of biological chemistry.

[3]  A. Köttgen,et al.  An intermediate-effect size variant in UMOD confers risk for chronic kidney disease , 2021, medRxiv.

[4]  R. Handsaker,et al.  Protein-coding repeat polymorphisms strongly shape diverse human phenotypes , 2021, Science.

[5]  J. Kellum,et al.  KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury. , 2021, American journal of physiology. Renal physiology.

[6]  S. Dhanasekaran,et al.  Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response , 2021, Proceedings of the National Academy of Sciences.

[7]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[8]  K. Dahan,et al.  Clinical and Genetic Spectra of Autosomal Dominant Tubulointerstitial Kidney Disease due to Mutations in UMOD and MUC1. , 2020, Kidney international.

[9]  Dan Zhang,et al.  Construction of a human cell landscape at single-cell level , 2020, Nature.

[10]  K. Amann,et al.  Molecular diagnosis of kidney transplant failure based on urine , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  Tetsuhiro Tanaka,et al.  Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storage. , 2019, Kidney international.

[12]  Karsten B. Sieber,et al.  Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria , 2019, Nature Communications.

[13]  P. Ratcliffe,et al.  Mechanisms of hypoxia signalling: new implications for nephrology , 2019, Nature Reviews Nephrology.

[14]  K. Eckardt,et al.  Autosomal dominant tubulointerstitial kidney disease , 2019, Nature Reviews Disease Primers.

[15]  Karsten B. Sieber,et al.  Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels , 2019, Nature Genetics.

[16]  A. Gnirke,et al.  Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy , 2019, Cell.

[17]  Allon M Klein,et al.  Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data. , 2019, Cell systems.

[18]  James M. Eales,et al.  Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies , 2019, Nature Communications.

[19]  G. Schley,et al.  HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease. , 2018, Kidney international.

[20]  James M. Eales,et al.  Molecular insights into genome-wide association studies of chronic kidney disease-defining traits , 2018, Nature Communications.

[21]  K. Ribbeck,et al.  Mucins and Their Role in Shaping the Functions of Mucus Barriers. , 2018, Annual review of cell and developmental biology.

[22]  Laleh Haghverdi,et al.  Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors , 2018, Nature Biotechnology.

[23]  E. Salido,et al.  Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations , 2018, Scientific Reports.

[24]  A. Köttgen,et al.  Genetic and environmental risk factors for chronic kidney disease. , 2017, Kidney international supplements.

[25]  P. Ratcliffe,et al.  Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway , 2017, PLoS genetics.

[26]  R. Sandford,et al.  A novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  M. Copin,et al.  Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[28]  V. Haase.  Oxygen sensors as therapeutic targets in kidney disease. , 2017, Nephrologie & therapeutique.

[29]  A. Hartmann,et al.  Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer , 2016, Nature Communications.

[30]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[31]  K. Eckardt,et al.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond , 2016, Nature Reviews Nephrology.

[32]  K. Hallows,et al.  Muc1 is protective during kidney ischemia-reperfusion injury. , 2015, American journal of physiology. Renal physiology.

[33]  M. Uder,et al.  Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. , 2014, Kidney international.

[34]  P. Mukherjee,et al.  MUC1: a multifaceted oncoprotein with a key role in cancer progression. , 2014, Trends in molecular medicine.

[35]  Matteo Trudu,et al.  Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression , 2013, Nature Medicine.

[36]  Eric S. Lander,et al.  Mutations causing medullary cystic kidney disease type 1 (MCKD1) lie in a large VNTR in MUC1 missed by massively parallel sequencing , 2013, Nature Genetics.

[37]  M. Nangaku,et al.  Frontiers in Research Review: Kidney Oxygenation in Health and Disease Regulation of hypoxia-inducible factor in kidney disease , 2013 .

[38]  Fabian J Theis,et al.  Genome-wide association analyses identify 18 new loci associated with serum urate concentrations , 2012, Nature Genetics.

[39]  G. Schley,et al.  Selective stabilization of HIF-1α in renal tubular cells by 2-oxoglutarate analogues. , 2012, The American journal of pathology.

[40]  S. Kroening,et al.  Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells , 2012, PloS one.

[41]  Y. J. Kim,et al.  Meta-analysis identifies multiple loci associated with kidney function–related traits in east Asian populations , 2012, Nature Genetics.

[42]  G. Semenza,et al.  Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.

[43]  B. Buchholz,et al.  Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model , 2009, Proceedings of the National Academy of Sciences.

[44]  E. Birney,et al.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.

[45]  K. Kimura,et al.  Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. , 2008, American journal of physiology. Renal physiology.

[46]  R. Johnson,et al.  Acute postnatal ablation of Hif-2α results in anemia , 2007, Proceedings of the National Academy of Sciences.

[47]  D. Darling,et al.  MUC1 splice variants in human ocular surface tissues: possible differences between dry eye patients and normal controls. , 2006, Experimental eye research.

[48]  X. Lens,et al.  Homozygosity for uromodulin disorders: FJHN and MCKD-type 2. , 2004, Kidney international.

[49]  M. Ligtenberg,et al.  A single nucleotide polymorphism in an exon dictates allele dependent differential splicing of episialin mRNA. , 1991, Nucleic acids research.

[50]  A. Howie,et al.  Epithelial membrane antigen in normal and proteinuric glomeruli and in damaged proximal tubules , 1986, The Journal of pathology.

[51]  E. Heyderman,et al.  A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue. , 1979, Journal of clinical pathology.

[52]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..